Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial

por Kuebler, Peter J., Shaw, Brian I., Leadabrand, Kaitlyn S., Mehrotra, Megha L., Grant, Robert M., Kallás, Esper G., Nixon, Douglas F.
Publicado 2016

SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California

por Lamba, Katherine, Bradley, Heather, Shioda, Kayoko, Sullivan, Patrick S, Luisi, Nicole, Hall, Eric W, Mehrotra, Megha L, Lim, Esther, Jain, Seema, Kamali, Amanda, Sanchez, Travis, Lopman, Benjamin A, Fahimi, Mansour, Siegler, Aaron J
Publicado 2021

CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021–July 2021

por Mehrotra, Megha L, Lim, Esther, Lamba, Katherine, Kamali, Amanda, Lai, Kristina W, Meza, Erika, Szeto, Irvin, Robinson, Peter, Tsai, Cheng-ting, Gebhart, David, Fonseca, Noemi, Martin, Andrew B, Ley, Catherine, Scherf, Steve, Watt, James, Seftel, David, Parsonnet, Julie, Jain, Seema
Publicado 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021

por Couture, Alexia, Lyons, B Casey, Mehrotra, Megha L, Sosa, Lynn, Ezike, Ngozi, Ahmed, Farah S, Brown, Catherine M, Yendell, Stephanie, Azzam, Ihsan A, Katić, Božena J, Cope, Anna, Dickerson, Kristen, Stone, Jolianne, Traxler, L Brannon, Dunn, John R, Davis, Lora B, Reed, Carrie, Clarke, Kristie E N, Flannery, Brendan, Charles, Myrna D
Publicado 2022